{
    "Trade/Device Name(s)": [
        "ENVOY 500 CK Reagent Kit",
        "ENVOY\u00ae500 CK REAGENT KIT"
    ],
    "Submitter Information": "ELITech Clinical Systems SAS",
    "510(k) Number": "K141265",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122083"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHW"
    ],
    "Summary Letter Date": "July 18, 2014",
    "Summary Letter Received Date": "May 15, 2014",
    "Submission Date": "May 14, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatine kinase (CK)",
        "Creatine phosphokinase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ENVOY 500 Chemistry System",
        "ENVOY 500 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "UV Method Kinetic",
        "Kinetic determination based on IFCC recommendations"
    ],
    "Methodologies": [
        "Kinetic-UV assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for ENVOY 500 CK Reagent Kit for quantitative determination of creatine kinase in serum and plasma using the ENVOY 500 Chemistry System.",
    "Indications for Use Summary": "Intended for the quantitative in vitro diagnostic determination of creatine kinase (CK) in human serum and plasma using the ENVOY 500 Chemistry System; not intended for point of care use; aids in diagnosis and treatment of myocardial infarction and muscle diseases such as Duchenne-type muscular dystrophy.",
    "fda_folder": "Clinical Chemistry"
}